Duska Therapeutics Acquires P2 Receptor-Based Technology for Potential Treatment of Glaucoma

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Source:
    Business Wire, June 15, 2005